Close Menu

This article has been corrected to make clear that Genomic Health expects to make IVD products available in France and Germany in 2020.

NEW YORK (GenomeWeb) – Following a year of major milestones, Genomic Health CEO Kim Popovits said that the company expects to sustain and grow its momentum in 2019 with a focus on increasing adoption of its core breast cancer product in the US, pushing international expansions, and continuing to diversify its test menu.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.